- Home
- LBRDA vs PCVX Comparison
LBRDA vs PCVX Comparison
Compare LBRDA & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDA
- PCVX
- Stock Information
- Founded
- LBRDA 2014
- PCVX 2013
- Country
- LBRDA United States
- PCVX United States
- Employees
- LBRDA N/A
- PCVX N/A
- Industry
- LBRDA Cable & Other Pay Television Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- LBRDA Telecommunications
- PCVX Health Care
- Exchange
- LBRDA Nasdaq
- PCVX Nasdaq
- Market Cap
- LBRDA 11.2B
- PCVX 9.6B
- IPO Year
- LBRDA N/A
- PCVX 2020
- Fundamental
- Price
- LBRDA $77.30
- PCVX $30.65
- Analyst Decision
- LBRDA Buy
- PCVX Strong Buy
- Analyst Count
- LBRDA 3
- PCVX 9
- Target Price
- LBRDA $94.00
- PCVX $136.50
- AVG Volume (30 Days)
- LBRDA 157.6K
- PCVX 3.7M
- Earning Date
- LBRDA 05-07-2025
- PCVX 05-07-2025
- Dividend Yield
- LBRDA N/A
- PCVX N/A
- EPS Growth
- LBRDA 29.85
- PCVX N/A
- EPS
- LBRDA 6.08
- PCVX N/A
- Revenue
- LBRDA $1,016,000,000.00
- PCVX N/A
- Revenue This Year
- LBRDA $5.22
- PCVX N/A
- Revenue Next Year
- LBRDA $2.34
- PCVX N/A
- P/E Ratio
- LBRDA $12.87
- PCVX N/A
- Revenue Growth
- LBRDA 3.57
- PCVX N/A
- 52 Week Low
- LBRDA $47.17
- PCVX $27.66
- 52 Week High
- LBRDA $100.44
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- LBRDA 45.40
- PCVX 26.64
- Support Level
- LBRDA $74.94
- PCVX $28.58
- Resistance Level
- LBRDA $79.45
- PCVX $32.72
- Average True Range (ATR)
- LBRDA 3.71
- PCVX 3.75
- MACD
- LBRDA -0.47
- PCVX 0.12
- Stochastic Oscillator
- LBRDA 42.65
- PCVX 29.09
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.